Japan approves Sapien XT valve

Candace Stuart | | Cardiovascular Business | Structural Heart Disease

Japan’s regulatory body has approved Edwards Lifesciences’ Sapien XT valve for surgical aortic valve replacement.

A clinical trial to assess the Sapien XT valve in Japan was conducted at Osaka University Hospital in Osaka, Sakakibara Heart Institute in Tokyo and Kurashiki Central Hospital in Okayama. Irvine, Calif.-based Edwards Lifesciences said it is awaiting reimbursement approval from the Japanese Ministry of Health, Labor and Welfare before fully launching the valve.

The valve was commercially launched in Europe in 2010. It remains an investigational device in the U.S.

Candace Stuart, Contributor

Related Content

CMS proposes Medicare coverage for transcatheter tricuspid valve replacement
Hydra TAVR valve gains key approval as global reach continues to grow
SAVR outperforms TAVR in patients with bicuspid aortic valves
Treating AFib patients with TAVR still linked to elevated risks
Heart surgeons detail world’s first robotic heart procedure of its kind
Years of progress have made TAVR more effective when treating concomitant mitral stenosis

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.